ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
SAFC, the fine chemicals business of Sigma-Aldrich, has acquired Molecular Medicine BioServices, a Carlsbad, Calif.-based producer of viruses used to deliver DNA, RNA, and other biopharmaceutical drugs. "The acquisition of MMB continues our push into niche biologics," says SAFC President Frank Wicks. He says the ability to manufacture viruses complements SAFC's transgenic extraction and purification operation in St. Louis and a bacterial fermentation facility under construction in Israel. According to Wicks, SAFC had considered building its own virus plant in St. Louis. MMB, founded in 1997, employs 60 people and has annual sales of about $12 million.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter